PROVIDER PROFILE · NPI 1477994358

Michael MorkosMD

EndocrinologyChicago, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

830

Unique beneficiaries

—

Total services

1,481

Distinct HCPCS

Medicare payment

$82K

Peer benchmark

Total Medicare services vs. 262 Endocrinology providers in IL — above median (cohort median 1,061).

PRESCRIBING · PART D · 2024

Total Rx claims

3,578

Beneficiaries

—

Total drug cost

$1.9M

Distinct drugs

Brand share

60.7%

Top prescribed drugs

Tirzepatide338 claims

Methimazole320 claims

Levothyroxine Sodium264 claims

Levothyroxine Sodium242 claims

Alendronate Sodium161 claims

QUALITY · MIPS · 2024

Final MIPS score

86.9

Quality

71.5

Cost

75.1

Improvement activities

40.0

Promoting interop.

98.0

Payment adjustment

0.50%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history